The role of angiogenesis, assessed by microvessel count (MVC), on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

A. P. Meert, B. Martin, M. Paesmans, J. M. Verdebout, T. Berghmans, J. J. Lafitte, P. Delmotte, C. Mascaux, J. P. Sculier (Brussels, Belgium; Lille, France)

Source: Annual Congress 2002 - Thoracic oncology: biology
Session: Thoracic oncology: biology
Session type: Oral Presentation
Number: 140

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. P. Meert, B. Martin, M. Paesmans, J. M. Verdebout, T. Berghmans, J. J. Lafitte, P. Delmotte, C. Mascaux, J. P. Sculier (Brussels, Belgium; Lille, France). The role of angiogenesis, assessed by microvessel count (MVC), on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Eur Respir J 2002; 20: Suppl. 38, 140

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of EGFR expression in the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
Source: Eur Respir J 2001; 18: Suppl. 33, 478s
Year: 2001

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
Source: Eur Respir J 2001; 18: 705-719
Year: 2001



The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
Source: Eur Respir J 2002; 20: 975-981
Year: 2002



Role of ras protoncogene in survival of patients with lung cancer: a systematic literature review and meta-analysis
Source: Eur Respir J 2004; 24: Suppl. 48, 478s
Year: 2004

COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005


Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations
Source: Eur Respir J 2011; 39: 9-28
Year: 2012



Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations
Source: Eur Respir J 2012; 39: 9-28
Year: 2012



Late-breaking abstract: Is primary tumour standardized uptake value (SUV) an independent prognostic factor for non small cell lung cancer (NSCLC)? A meta-analysis based on individual data
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011

Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis.
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021



Relevance of clinical TNM-staging in small cell lung cancer (SCLC) for survival – A retrospective case study in 633 patients
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Validation and comparison of several published prognostic systems for patients with small cell lung cancer
Source: Eur Respir J 2011; 38: 657-663
Year: 2011



Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019


A meta-analysis assessing the prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021



Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
Source: Eur Respir J 2001; 18: Suppl. 33, 319s
Year: 2001

Systematic review of the effect of chemotherapy on quality of life (QoL) and symptom control in patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Lung cancer treatment
Year: 2006


Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer (ED SCLC)
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019


Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis
Source: ERJ Open Res, 5 (4) 00179-2019; 10.1183/23120541.00179-2019
Year: 2019



The prognosis of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in lung cancer and the association with treatment: a retrospective study>
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017

Limited role of Ki-67 in lung carcinoid tumor patients predicting overall short-term survival,A single institution experience
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018


A retrospective study of the cause and impact of delayed diagnosis of lung cancer (LC)
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008